Abstract:Purpose of review: Describe and evaluate the integration of 3D printing-related innovations into current cardiovascular treatment paradigms and examine the state of regulatory and reimbursement hurdles ahead. Recent findings: Mounting years of clinical experience have established the utility of printed models of patient anatomy in numerous treatment and teaching scenarios, most notably as pre- and intra-procedural planning tools guiding decision-making for congenital heart disease and catheter-based interventions. In part due to a continued lack of reimbursement and under-defined (and slow to evolve) regulatory status, these use cases remain largely investigational even as they grow increasingly routine. Patients, physicians, and/or imaging centers therefore remain burdened by the associated cost to create such models, and the perceptual and decision-making enhancements, while demonstrable and significant, still may not clearly or independently justify a potentially high cost. Simulation and implantable device applications may represent a deeper well of unrealized value in cardiovascular intervention; however, further development of these applications relies on-and is throttled by-progress in material science and tissue-engineering research. The relevance of simulation applications in recent years is also now in competition with digital analogs including augmented and virtual reality. Innovative incorporation of alternative manufacturing processes such as porous scaffold infusion, injection molding, and vascular mesh forming can provide immediate access to more realistic tissue-mimicking materials and custom implantable devices, while comparable and directly printable materials continue to be developed. Tissue-engineering applications remain years if not decades away from a more substantive role in translatable clinical research. Regulatory challenges associated with in-house manufacture of implantable investigational devices are complex and subject to change, and the success of some in navigating these hurdles in non-cardiovascular applications is instructive and encouraging. Complex geometries characterizing cardiovascular anatomy are an ideal use case for translating the perceptual advantages of printed models of patient anatomy into better decision-making, especially so in the setting of congenital or post-surgical anatomy. Procedural planning applications take further advantage of the demonstrably robust dimensional reproduction of patient anatomy, with notably rapid integration into surgical and catheter-based intervention workflows. Despite a continued lack of codification in the healthcare system, 2018 could be a milestone year for 3D printing services, pending a successful application for a CPT Category III designation.

A Step towards the Future

3D Printing for Cardiovascular Applications: From End-to-End Processes to Emerging Developments

Manufacturing Better Outcomes in Cardiovascular Intervention: 3D Printing in Clinical Practice Today

Three-Dimensional Printing Applications in Percutaneous Structural Heart Interventions

The Use of Three-Dimensional Printing in Cardiac Structural Disease: A Review

3D Printed Models in Cardiovascular Disease: An Exciting Future to Deliver Personalized Medicine

Three-Dimensional Bioprinting in Cardiovascular Disease: Current Status and Future Directions

Printing@Clinic: from Medical Models to Organ Implants

Current and future applications of 3D printing in congenital cardiology and cardiac surgery.

3-Dimensional printing in vascular disease: From manufacturer to clinical use

Three-dimensional printing in orthopaedic surgery: A review of current and future applications

Application of 3 D Printing Techniques in Treatment of Congenital Heart Disease

The future of personalized cardiovascular medicine demands 3D and 4D printing, stem cells, and artificial intelligence

Cardiac patient-specific three-dimensional models as surgical planning tools

Pictorial review current and future applications of 3 D printing in congenital cardiology and cardiac surgery

Empowering Precision Medicine: The Impact of 3D Printing on Personalized Therapeutic

Clinical Applications of Patient-Specific 3D Printed Models in Cardiovascular Disease: Current Status and Future Directions

3D Bioprinted Cardiac Tissues and Devices for Tissue Maturation

Three-Dimensional Printing in Minimally Invasive Cardiac Surgery: Optimizing Surgical Planning and Education with Life-Like Models

219Three-dimensional printing as a cutting-edge, versatile and personalizable vascular stent manufacturing procedure: Toward tailor-made medical devices

3D printing technology and its revolutionary role in stent implementation in cardiovascular disease